Skip to content
3D Printing Certification

Fluicell introduces substantial resolution 3D bioprinter, the Biopixlar

certification

Fluicell, a healthcare engineering business spun out from the Chalmers University of Engineering, Sweden has released a large-resolution 3D bioprinter known as Biopixlar. This technique is an all-in-just one discovery system made to make novel tissue versions for drug enhancement, as perfectly as sickness and regenerative medication exploration.

Biopixlar® | 3D Single-Cell Bioprinting

Fluicell biotechnology

Started in 2012, Fluicell develops platforms for cell habits investigation. Prior to the launch of the Biopixlar 3D printer, the organization released its BioPen, reportedly the initial single-cell lab-on-a-idea resource for targeting individual cells in vitro. An ion channel screening platform named the Dynaflow Solve program was also developed by Fluicell.

As its latest system, the Biopixlar enables printing of many diverse cell sorts in 1 run with high precision and resolution. The 80cm (H) x 70cm (W) x57cm (D) system consists of a micromanipulator arm and a motorized stage to exactly position its printer head and sample.

A special element of the Biopixlar is its gamepad interface. This lets for handheld control to position the printer head and deposit cells. Furthermore, an onboard multi-coloration fluorescence imaging setup allows genuine-time monitoring of the printing system and submit-print analysis.

Fluicell's Biopixlar 3D bioprinter. Photo via Fluicell.
Fluicell’s Biopixlar 3D bioprinter. Photo by means of Fluicell.

Biopixlar complex specifications 

The creation of tissues and disorder models can complement and reduce animal screening in the intermediate phases of drug progress, producing decreased development costs and much less ethical issues. Such versions also accelerate the enhancement of personalized medication with the use of affected individual-unique cells. According to Fluicell, Biopixlar features the optimal resolution for medical investigate products.

The value for the Biopixlar has yet to be disclosed.

Printing Technologies Microfluidic hydrodynamic confined circulation technological know-how
Printing Dimension
Printing Manner Direct printing of mobile suspension devoid of the have to have for gel matrix
Printing Area Mobile dish with tradition medium or buffer
Deposition Method From unique to 1000’s of cells
Microfluidic Printer head Exchangeable solitary-use consumable designed from a medical-grade elastomer. Just about every has the capacity to hold up to 3 cell wells.
Camera 3 Mpx large sensitivity 1920 x 1080
Slide Holders For 35 mm ø cell dish
For 50 mm ø mobile dish
For microtiter plate (6 wells)
Motion Precision 2 micrometers
Application Java – cross-system appropriate
Handle Interface Gamepad

 

A 3D tissue model printed with skin cancer cells as a base line ( purple), epithelial cells as a middle layer (red) and skin cancer cells as a top layer (green). Photo via Fluicell.
A 3D tissue design printed with pores and skin cancer cells as a foundation line ( purple), epithelial cells as a center layer (red) and pores and skin most cancers cells as a major layer (inexperienced). Image through Fluicell.

Subscribe to the 3D Printing certification Business newsletter, like us on Fb and comply with us on Twitter for all the hottest 3D bioprinting news. Check out 3D Printing certification Work opportunities for new opportunities in additive production certification.

Highlighted picture shows Fluicell’s Biopixlar 3D bioprinter. Photograph by way of Fluicell.